... biotechnology company developing PAS-004, a next ... Ildefonso Rodriguez M.D., acting as principal investigator for the San Antonio, TX site.
News
- Pasithea Therapeutics Announces Opening of Enrollment in the U.S. for its Phase 1 Trial of PAS-004
- Cedar pollen to fall, live oak pollen to rise | TPR - Texas Public Radio
Local allergists report cedar pollen counts that trigger "cedar fever" are beginning to drop into the low-to-moderate range in San Antonio more ...
- Six startups combine into one dermatology biotech based in Boston and Geneva
San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay ... Biotech, Nira Biosciences and Vimela Therapeutics. UNLOCK EVERY ...
- Tuberculosis cases rise, but public health agencies say they lack the resources to keep up
San Antonio is one of a handful of U.S. sites that received a 10-year research funding grant from the CDC. But funding for prevention, treatment and ...
- Pasithea Therapeutics Announces Opening of Enrollment in the U.S. for its Phase 1 Trial of PAS-004
Ildefonso Rodriguez M.D., acting as principal investigator for the San Antonio, TX site. There are also three other clinical trial sites in ...